- Juniorstocks.com
- Posts
- Pelosi Prints Millions, UnitedHealth on Life Support, Buffett Bets Big on Booze
Pelosi Prints Millions, UnitedHealth on Life Support, Buffett Bets Big on Booze
You're receiving this newsletter as a subscriber to JuniorStocks.com. Join the conversation on our socials below.
Featured Article this week:
Pelosi’s $4.7M Trading Buzz: A viral X post by @PelosiTracker_ claims Nancy Pelosi made $4.7 million in one day of trading on May 12—26x her annual congressional salary—though this figure is based on estimates from QuiverQuant and lacks official disclosure.
We are so back.
According to QuiverQuant, Nancy Pelosi has made $4,700,000 in the stock market today.
That's 26x her yearly salary.
In one day.
— Nancy Pelosi Stock Tracker ♟ (@PelosiTracker_)
5:17 PM • May 12, 2025
No Public Filings Confirm It (Yet): As of May 14, no STOCK Act filings validate the $4.7M gain; QuiverQuant’s data is speculative, based on past trades and market performance—not real-time brokerage records.
Optics vs. Legality: While Pelosi’s 2024 portfolio reportedly soared 92.5% (driven by big tech bets like NVIDIA), no laws were broken. But the lack of transparency fuels renewed debate over banning congressional stock trading.
UnitedHealth Group: Cheap Bargain or Value Trap?
The insurance giant has shed over 50% in just 6 months — here's what triggered the collapse.
UnitedHealth’s Market Value Implodes: Once trading above $600, UNH shares have crashed to ~$290, wiping out over $230 billion in market cap amid earnings cuts, a CEO shakeup, and growing regulatory scrutiny.
Medicare Advantage Fallout & V28 Shock: A rule change (V28) in how Medicare Advantage payments are calculated severely hit UNH’s core revenue stream; the company admitted it underestimated the impact, triggering a 13.5% forecasted earnings drop in 2025.
Legal, Political & Structural Pressure: The DOJ is reportedly investigating UnitedHealth for Medicare fraud; meanwhile, bipartisan lawmakers and Trump are targeting the company's business model—especially its pharmacy middleman role—leaving UNH with no clear path to recovery.
Buy or Avoid? Despite the steep drop, UNH is not a clear buy—regulatory threats, legal investigations and structural reliance on a fragile Medicare Advantage model create long-term risk. With earnings unlikely to recover before 2027 and leadership doubling down on past strategies, the stock currently looks more like a value trap than a bargain.

UnitedHealth Stock is Down over 50% in the past 6 Months
Market Snapshot This Week:
Tech Soars on AI Boom & Earnings Beats
NVIDIA (+15.54%), AMD (+13.75%), and AVGO (+9.63%) surged on blowout earnings and bullish AI infrastructure demand. Microsoft (+2.63%), Apple (+6.29%), and Alphabet/Google (+8.69%) followed, buoyed by continued optimism around GenAI deployment and cloud spending resilience. CrowdStrike, Palantir, and Oracle also jumped on stronger guidance tied to enterprise AI adoption.Tesla, Meta, and Uber Power Consumer & Comms Rally
Tesla (+16.58%) rocketed on news of a strategic AI fleet expansion and improved China sales. Meta (+7.05%) was lifted by ad spend recovery and rumoured release of a proprietary AI chip. Uber (+11.77%) climbed on stronger-than-expected mobility growth and profitability outlook.Health Plans Collapse on Regulatory Shock
UnitedHealth (UNH -24.78%), Cigna (CI -7.43%), and CVS (-5.28%) plunged after the Trump administration proposed aggressive price caps and clawbacks tied to Medicare Advantage overpayments. The move rattled the entire healthcare plan segment, despite broader market gains.

All data current as of 1pm EST 05/16/2025
Top Viewed Articles this week:
We want your feedback on this week’s market insights! How’d we perform? 📈📉Let us know where we stand! 🚀 |